This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

The Cutting Room: Biotech or Internet?

Best Bet?

Him or Jim? YOU decide.

That's the word from Gary B. Smith. He thinks there's just not enough room for two kings at

In a last-minute showdown that would rival any Clint Eastwood movie (well, OK, maybe just his spaghetti westerns), Gary challenged Cramer to a contest: Who is the most popular?

In the action-packed Predictions segment of this week's "" on Fox News Channel, Gary B. reached for his holster. You see, he forecasts that biotech is better-named "biowreck" from here on out ... and that the Internet is a much smarter bet. Jim, on the other hand, predicts that biotech is on its way up again.

"Oh yeah?" smirked Gary. Get the readers to vote, he dared. Make it a popularity contest. So, if you vote for Internet, you're voting for him; if you go with biotech, it's a vote for Jim.

OK, so it was an impromptu challenge to a duel. But why don't we make it more formal?

Gary thinks that BBH (BBH), a Merrill Lynch exchange-traded portfolio of biotech stocks, is no longer the ticket to riches. Instead, he advocates investing in HHH (HHH), Merrill's Lynch's basket of Internet stocks.

What do you think? (Or, as Gary asks, WHO do you like?) Vote on our poll here .

This was just one of the match-ups in the show. There were lots of others....

Let It Ride vs. Grab Some Gains Now!

During Word on the Street, I asked: How do you protect your profits in this kind of market mania?

In one corner, Jim Cramer (doesn't he always seem to be on one side of every debate?). In the other, Graham Tanaka, whose mutual fund is up nearly 30% in the year to date.

Cramer's ready answer: Don't be a pig, you'll get slaughtered. Now's the time, he says, to trim some of the big winners in your portfolio. Take some money off the table!

Not so fast, Tanaka piped in. He's a buy-and-holder -- rare in these daytrading days -- and has owned Intel (INTC) for more than a decade.

Adam Lashinsky, our Silicon Valley correspondent, on whom I depend during this segment as the never-flinching voice of reason, reminds us of a simple rule: You've got to be able to sleep at night. This might be a good opportunity to re-evaluate your tolerance for risk and get out of some of those more volatile stocks that wake you up at 3 a.m.

The Classic: Da Charts vs. Da Fundies

Yep. Each show, this is one of my favorites. The Chartman takes on Mr. Fundamental, Adam Lashinsky. Chartman claims to know nothing about what a company does, relying only on charts for investment guidance, while Mr. Fundamental is the best in the business at figuring out the nuts and bolts of a company: bottom line, earnings and competitive advantage.

They take on the biggest biotech turned biowreck, Aviron (AVIR) (Gary's a bull, Adam bearish), then tackle MicroStrategy (MSTR), the software stock that cratered last week on earnings news ("I'd love to love it," says Gary, but he doesn't like the look of its chart. As for Adam, he's convinced it's a good company that will win out in the long term.)

Buy vs. Sell

Yep, Cramer takes on the stock market. (I know who I'm betting on!)

You've got a favorite stock? He's got an opinion (or two or three), giving you the bottom line on stocks you're asking about. This isn't like the typical boring old "buy, sell or hold" segments that fill most business programming. No wimpy "long-term holds" here. Cramer tells it like it is -- and he doesn't mince words. Jim doesn't know which stocks you'll bring up, but he lives this stuff every minute of every day, so you can count on a no-holds-barred response.

A couple of examples:

  • To Rich in Maryland, who wanted to know about First Union(FTU): "I wouldn't bank there. I wouldn't buy it."
  • To Fred in Michigan, re Cisco(CSCO): "I love Cisco's John Chambers. We should be using Chambers dollars instead of U.S. dollars."
  • Get the idea? Yet those are just two. JJC rocked through 18 stocks in four minutes.

    But now for the ultimate: Jim vs. Him, or Internet vs. Biotech. Cast your votes now!

    Naturally, I won't be voting. Think I'm a fool? I work with these guys! But I'll tell you one thing for sure, I wish I'd known Gary B. in high school. He gets a lot of points for candor. Remember when all the goodie-two-shoes insisted that the homecoming queen or student body president elections were really based on qualifications such as brains or experience?

    Yeah, right. They were one thing and one thing only: Popularity contests!

    This is a bit more, though, Gary -- and it's time for readers to weigh in on which is the way to go: Biotech or Internet.

    May the best man (sector) win!
    Brenda Buttner's column, Under the Hood, appears Thursdays. At time of publication, Buttner held no positions in any securities mentioned in this column, although holdings can change at any time. Under no circumstances does the information in this column represent a recommendation to buy or sell stocks or funds. While she cannot provide investment advice or recommendations, Buttner appreciates your feedback at .

    Check Out Our Best Services for Investors

    Action Alerts PLUS

    Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

    Product Features:
    • $2.5+ million portfolio
    • Large-cap and dividend focus
    • Intraday trade alerts from Cramer
    Quant Ratings

    Access the tool that DOMINATES the Russell 2000 and the S&P 500.

    Product Features:
    • Buy, hold, or sell recommendations for over 4,300 stocks
    • Unlimited research reports on your favorite stocks
    • A custom stock screener
    Stocks Under $10

    David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

    Product Features:
    • Model portfolio
    • Stocks trading below $10
    • Intraday trade alerts
    14-Days Free
    Only $9.95
    14-Days Free
    Dividend Stock Advisor

    David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

    Product Features:
    • Diversified model portfolio of dividend stocks
    • Updates with exact steps to take - BUY, HOLD, SELL
    Trifecta Stocks

    Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

    Product Features:
    • Model Portfolio
    • Intra Day Trade alerts
    • Access to Quant Ratings
    Real Money

    More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

    Product Features:
    • Access to Jim Cramer's daily blog
    • Intraday commentary and news
    • Real-time trading forums
    Only $49.95
    14-Days Free
    14-Days Free
    AAPL $110.78 0.36%
    FB $94.01 2.11%
    GOOG $641.47 2.32%
    TSLA $246.15 -0.57%
    YHOO $30.85 0.46%


    Chart of I:DJI
    DOW 16,776.43 +304.06 1.85%
    S&P 500 1,987.05 +35.69 1.83%
    NASDAQ 4,781.2640 +73.4890 1.56%

    Free Reports

    Top Rated Stocks Top Rated Funds Top Rated ETFs